Serveur d'exploration sur les pandémies grippales - Checkpoint (PascalFrancis)

Index « Mots-clés originaux en anglais » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Keywords

Pour accéder à une entrée :

Les termes de plus forte occurence

1249Influenza
759Influenza A virus
728Human
716Influenza A
624Public health
622Vaccine
522H1N1 influenza
434Infection
404Prevention
395Epidemiology
385Vaccination
314Epidemic
300Antiviral
295Influenza A (H1N1)
255Immunoprophylaxis
209Child
198Sanitary surveillance
188Influenzavirus A(H1N1)
183Avian influenza
182Medicine
171Influenzavirus
165Treatment
157Oseltamivir
1502009
146Microbiology
132Avian influenzavirus
131France
121Pediatrics
119World
114Swine
112Animal
104Virus
103Mouse
102Transmission
101Hemagglutinin
98Review
96United States
95Seasonal variation
95Europe
94Detection
93Immunological adjuvant
91Diagnosis
90Risk factor
87Immunogenicity
87Immune response
86Veterinary
86Resistance
86Prognosis
84Mortality
83Check
81Intensive care
80Pregnancy
80Hospitalization
77Surveillance
74Hospital
73Influenzavirus A(H5N1)
73Exo-α-sialidase
71Viral disease
71Toxicity
71Resuscitation
69Virology
69Tropical medicine
65Method
65Comparative study
63Subtype
63Pneumonia
63Antibody
62Reverse transcription polymerase chain reaction
59Mutation
59Health care staff
58Immunization
56Symptomatology
56Efficiency
53Pandemic
51Health staff
50Humoral immunity
49Survey
48Risk
47Recommendation
47Modeling
46Health policy
45Respiratory tract
45Obstetrics
45Health
45Gynecology
45Gene
44Real time
44Female
43Inactivated strain
42Evaluation
42Disease
42Age
41AIDS
40Nosocomial infection
40Models
40Drug
40Acute
39Woman
39Genetic reassortment
39Flulike syndrome
39China
39Case history
39Care
39Australia
39Attenuated strain
39Antigen
39Adult
38Polymerase chain reaction
38Pathogenicity
37WHO
37Respiratory disease
37In vitro
37Emergency
36Typing
36Planning
36Complication
36Anesthesia
35Emerging disease
33Zanamivir
33School environment
33Replication
33Prevalence
32Vaccination coverage
32Serology
32Risk management
32Rapid technique
32Pig
32Hygiene
32Genetics
32Elderly
31Population
31Patient
31Influenzavirus A
30United Kingdom
30Neuraminidase inhibitor
30Hong Kong
30Cohort study
29Spain
29Aves
28Preparation
28Immunoprotection
28Genetic vaccine
28Clinical management
27Vector
27Protein
27Porcine influenzavirus
27Pathogenesis
27Ethics
27Crisis
26Strain
26Network
26Homotransplantation
26Canada
26Bibliographic review
25Teaching
25Strategy
25Sensitivity
25Intensive care unit
25Incidence
25Ferret
25Evolution
25Clinical trial
25Animal model
24T-Lymphocyte
24Origin
24Organization
24Japan
24Communication
24Chemotherapy
24Attitude
23Virulence
23Safety
23Physician
23Identification
23England
22Treatment efficiency
22Quantitative analysis
22Immunology
22History
22Genotype
21Respiratory distress
21Molecular epidemiology
21Laboratory
21Cytokine
21Cardiology
20Influenza B
20General practitioner
20Emergency department
20Dragging
20Death
20Costs
20Circulatory system
20Cell culture
19Sanitary program
19Plane
19Netherlands
19Management
19Germany
19General practice
19Estimation
19Contagion
19Communicable disease
19Cellular immunity
18Treatment resistance
18Scientific research
18Risk analysis
18Policy
18Neutralizing antibody
18Epizootics
18Cross reaction
18Critically ill
18Case study
18Behavior
17Virus like particle
17Viral load
17Transplantation
17Severe acute respiratory syndrome
17Protection
17Mixed infection
17Intranasal administration
17Human immunodeficiency virus
17Hospital environment
17Developing countries
16Simulation
16Poultry
16Nervous system diseases
16Italy
16Infant
16Antigenic determinant
16Amantadine
15Zoonosis
15Uptake
15Pneumology
15Pharmacovigilance
15Pathogenic
15Monoclonal antibody
15Knowledge
15Health service
15Chicken
15Bacteriosis
14Use
14Nurse
14New Zealand
14Morbidity
14Lung
14Immunity
14Household
14Hematology
14Hand
14Cross protection
14Asia
13Vietnam
13Urban environment
13Turkey
13Transmission from man to man
13Secondary effect
13Season
13Recipient
13Prospective
13Production
13Predictive factor
13Performance evaluation
13Peramivir
13Multiplex polymerase chain reaction
13Mexico
13Medical screening
13Mammalia
13Malignant tumor
13Information
13India
13Immune deficiency
13High risk
13Guillain-Barré syndrome
13Graft
13Decision making
13Cross immunity
13Characteristics
13Century 20
13Association
13Adaptation
13Accessibility
12Taiwan
12Primary health care
12Pharmaceutical industry
12Mass media
12Internet
12Inflammation
12Impact study
12Clinical biology
12Balance
12Army
11Travel
11Transmission from animal to man
11Streptococcus pneumoniae
11Severe
11Respiratory failure
11Research and development
11RNA-directed DNA polymerase
11Occupational medicine
11Nucleoprotein
11Neutralization
11Military environment
11Mathematical model
11Kidney
11Isolation
11Health economy
11Enzyme inhibitor
11Economic aspect
11Cross sectional study
11Contamination
11Community acquired infection
11Case control study
11Anatomic pathology
11Adenoviridae
10Viral pneumonia
10Thailand
10Subunit
10Statistical data
10Social medicine
10Rimantadine
10Result
10Respiratory system infection
10Regulation
10Pharmacotherapy
10Perception
10Oxygenation
10Oxygen
10Nutritional status
10New York
10Methodology
10Mechanical ventilation
10Health and environment
10French
10Encephalopathy
10Development
10Compliance
10California
10Biological activity
10Bacteria
10Aerosols
10Adolescent
10Absenteeism
9Victoria
9Vaccine strain
9Sweden
9Student
9Specificity
9Social aspect
9Priority
9Prediction
9Obesity
9Newborn
9Multicenter study
9Mother
9Military
9Lung disease
9Hemagglutination
9Genome
9Drug combination
9Disaster
9Definition
9Critical study
9Coverage
9Community
9Civil service
9Chemoprophylaxis
9Belgium
9Antibiotic
9Adjuvant
8Winter
8Tuberculosis
8Transfusion
8Technique
8Targeting
8Target
8Spanish flu
8South east Asia
8Socioeconomic status
8Serum
8Reunion island
8Respiratory system
8Pneumococcal infection
8Phylogeny
8Phase I trial
8Pharmaceutical technology
8Personnel
8Peptides
8Occupational exposure
8Natural immunity
8Metaanalysis
8Intravenous administration
8Inhibitor
8Immunopathology
8Homes for the aged
8Follow up study
8Financing
8Fear
8Fatal course
8Etiology
8Dose
8Database
8Cost efficiency analysis
8Closure
8Clinical isolate
8CD4 T lymphocyte
8Brazil
8Belief
8B-Lymphocyte
8Argentina
8Antiparkinson agent
8Analysis
8Acceptance
7Trend
7Taxonomy
7Switzerland
7Staphylococcus aureus
7South Korea
7South Africa
7Solid organ
7School
7Rheumatology
7Responsibility
7Renal failure
7Recombinant protein
7Rate
7Randomization
7Professional practice
7Phylogenetic tree
7Phase II trial
7Optimization
7Ontario
7Occupational role
7Narcolepsy
7Multiple
7Mucosa
7Metabolic diseases
7Mechanism of action
7Inequality
7In vivo
7Hypoxemia
7Host
7Hemorrhage
7Hemodialysis
7Hematopoietic cell
7Heart
7Epidemics
7Distribution
7Dissemination
7Determinant
7DNA
7Cytotoxicity
7Cytotoxic T lymphocyte
7Bioterrorism
7Baculoviridae
7Associated virus
7Ambulatory
6Work place
6Uncertainty
6Tropism
6Timing
6Stem cell
6Statistics
6Sorting
6Social perception
6Singapore
6Sialic acid
6Sex
6Severity score
6Sensitivity resistance
6Saudi Arabia
6Reservoir
6Refusal
6Rearing
6RNA
6Questionnaire
6Quebec
6Public health organization
6Proposition
6Norway
6Monkey
6Mechanism
6International
6International policy
6International cooperation
6Interferon
6Inhibition
6Indonesia
6Immunotherapy
6IgA
6Human respiratory syncytial virus
6Hospital organization
6Hospital admission
6Government
6Formation
6Firm
6Fever
6Emergence
6Early
6Drug susceptibility test
6Diffusion

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/PandemieGrippale.storage/PandemieGrippaleV1/Data/PascalFrancis/Checkpoint/KwdEn.i.hfd| SxmlCut idx/l | grep ...  

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021